Bowel Cancer News and Research

RSS

Bowel Cancer or colorectal cancer is cancer that occurs in the colon or rectum. Sometimes it is called colon cancer, for short. Colorectal cancer is the second leading cancer killer in the United States, but it doesn’t have to be.

Blood disorder medicines could be used for treating stomach and bowel cancer

Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.

5 Feb 2014

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Advanced melanoma affects around 2,000 people per year in the UK. Advanced melanoma describes a melanoma that has spread from its site of origin to other areas of the body.

22 Jan 2014

Queen's University to lead €6 million European study to find new treatments for bowel cancer

Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.

12 Dec 2013

Queen's University heads key European study to find new treatments for bowel cancer

Queen's University has announced it is to lead a €6 million European study to find new treatments for bowel cancer.

11 Dec 2013

Newly discovered receptor may help in early diagnosis and treatment for sepsis

Sepsis, or septicaemia, is a devastating disease that is difficult to diagnose early and for which treatment options are limited. The number of deaths from sepsis exceeds those from lung cancer, and from breast and bowel cancer combined.

4 Dec 2013

HCSA Annual Conference sponsored by PENTAX Medical to focus on new health procurement strategy

PENTAX Medical is a key sponsor of this year’s Health Care Supply Association Annual Conference and Exhibition, which takes place in Manchester, 13-14 November. One of the keynote speakers – Peter Smith – will be presenting the PENTAX Medical sponsored talk entitled: “The new health procurement strategy – a commentator and supplier view”, which takes place on Thursday 14th November, at 9am.

From PENTAX Medical Company 7 Nov 2013

King's College researchers identify new biomarker that detects sepsis in blood

Researchers at King's College London have identified a biomarker - a biological 'fingerprint' - for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.

17 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.

12 Sep 2013

New antibodies estimate risk of polyps developing into bowel cancer

Polyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it has not been possible to precisely estimate the risk of these polyps developing into bowel cancer.

19 Aug 2013

Publication of death rates: an interview with Dr Kate Walker, London School of Hygiene and Tropical Medicine

The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England’s “Everyone Counts” policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.

15 Aug 2013

Metabolic fingerprinting accurately determines stages of bowel cancer

It is possible to see how advanced a bowel cancer is by looking at its metabolic 'fingerprint', according to new research.

13 Aug 2013

Western dietary pattern associated with increased risk of colorectal cancer

Fizzy drinks, cakes, biscuits, crisps and desserts have all been identified as risk factors for bowel cancer, according to new research.

16 Jul 2013

Research suggests that publication of death rates unlikely to detect poorly performing surgeons

New research published in The Lancet suggests that the publication of death rates for individual surgeons in England, launched for the first of a new group of 10 specialties last week, is unlikely to correctly identify poorly performing surgeons in some specialties, because low numbers of key operations lead to unreliable results.

9 Jul 2013

Mouse study identifies new treatment options for bowel cancer

Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person's genetic profile.

9 Jul 2013

New study could help increase survival rates of people with colorectal tumours

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

24 May 2013

Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Colorectal cancer is the third most common cancer in men and second in women, with over 1.2 million cases diagnosed worldwide in 2008.

14 May 2013

Low bowel cancer survival in the UK likely to be due to differences in staging and treatment

Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.

17 Apr 2013

Survival rate for bowel cancer patients lower in UK, new research finds